Literature DB >> 4050940

Endogenous iridocyclitis relieved during treatment with bromocriptine.

L P Hedner, G Bynke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4050940     DOI： 10.1016/0002-9394(85)90697-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  9 in total

Review 1.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

Review 2.  Neuroimmune mechanisms in health and disease: 2. Disease.

Authors:  H Anisman; M G Baines; I Berczi; C N Bernstein; M G Blennerhassett; R M Gorczynski; A H Greenberg; F T Kisil; R D Mathison; E Nagy; D M Nance; M H Perdue; D K Pomerantz; E R Sabbadini; A Stanisz; R J Warrington
Journal:  CMAJ       Date:  1996-10-15       Impact factor: 8.262

Review 3.  Rheumatic manifestations of pituitary tumors.

Authors:  S Stavrou; D L Kleinberg
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

4.  Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls.

Authors:  A M Jacobi; W Rohde; H D Volk; T Dörner; G R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

5.  Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats.

Authors:  M Neidhart
Journal:  Experientia       Date:  1996-09-15

6.  Elevated prolactin levels in human aqueous humor of patients with anterior uveitis.

Authors:  U Pleyer; D Gupta; E G Weidle; W Lisch; M Zierhut; H J Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient.

Authors:  A Vidaller; F Guadarrama; L Llorente; J B Méndez; F Larrea; A R Villa; D Alarcón-Segovia
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

8.  Neuroendocrine alterations in uveitis patients.

Authors:  H A Wollmann; U Pleyer; S Friedel; M Zierhut; H J Thiel; D Gupta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-05       Impact factor: 3.117

9.  Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.

Authors:  A G Palestine; C G Muellenberg-Coulombre; M K Kim; M C Gelato; R B Nussenblatt
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.